Dr. Khalid Alhourani, MD

NPI: 1831232636
Total Payments
$1,661
2024 Payments
$875.12
Companies
10
Transactions
23
Medicare Patients
1,742
Medicare Billing
$337,570

Payment Breakdown by Category

Travel$769.09 (46.3%)
Food & Beverage$746.81 (45.0%)
Education$144.89 (8.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Travel and Lodging $769.09 2 46.3%
Food and Beverage $746.81 20 45.0%
Education $144.89 1 8.7%

Top Paying Companies

Company Total Records Latest Year
Stryker Corporation $927.02 3 $0 (2024)
Medtronic USA, Inc. $144.89 1 $0 (2018)
Orthofix Medical, Inc. $131.77 1 $0 (2023)
Mylan Specialty L.P. $131.55 6 $0 (2024)
Grifols USA, LLC $102.55 1 $0 (2021)
Janssen Pharmaceuticals, Inc $70.56 4 $0 (2022)
PFIZER INC. $62.17 3 $0 (2024)
E.R. Squibb & Sons, L.L.C. $39.19 2 $0 (2024)
AstraZeneca Pharmaceuticals LP $26.31 1 $0 (2024)
Respiratory Technologies, Inc. $24.78 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $875.12 7 Stryker Corporation ($769.09)
2023 $409.15 7 Stryker Corporation ($157.93)
2022 $56.46 3 Mylan Specialty L.P. ($33.74)
2021 $139.89 3 Grifols USA, LLC ($102.55)
2018 $144.89 1 Medtronic USA, Inc. ($144.89)
2017 $35.28 2 Respiratory Technologies, Inc. ($24.78)

All Payment Transactions

23 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/21/2024 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $16.67 General
Category: IMMUNOLOGY
11/07/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $26.31 General
Category: Respiratory
09/20/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $22.93 General
Category: Anticholinergics, Inhaled
05/15/2024 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.19 General
Category: Cardiovascular
05/07/2024 Stryker Corporation SALVATION (Device) Travel and Lodging Cash or cash equivalent $12.89 General
Category: TRAUMA & EXTREMITIES
03/08/2024 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $25.93 General
Category: Anticholinergics, Inhaled
02/16/2024 Stryker Corporation SALVATION (Device) Travel and Lodging Cash or cash equivalent $756.20 General
Category: TRAUMA & EXTREMITIES
11/08/2023 Stryker Corporation AIR (Device) Food and Beverage In-kind items and services $157.93 General
Category: KNEES
09/27/2023 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $24.45 General
Category: Anticholinergics, Inhaled
09/22/2023 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $25.00 General
Category: Cardiovascular
08/15/2023 Orthofix Medical, Inc. Physio-Stim (Device), Physio-Stim Food and Beverage In-kind items and services $131.77 General
Category: Stimulator, Bone Growth, Non-Invasive
04/27/2023 Mylan Specialty L.P. YUPELRI (Drug) Food and Beverage In-kind items and services $24.50 General
Category: Anticholinergics, Inhaled
03/03/2023 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, PAXLOVID Food and Beverage In-kind items and services $20.04 General
Category: VACCINES
01/18/2023 PFIZER INC. OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG Food and Beverage In-kind items and services $25.46 General
Category: IMMUNOLOGY
07/13/2022 Mylan Specialty L.P. Yupelri (Drug) Food and Beverage In-kind items and services $21.91 General
Category: Anticholinergics, Inhaled
03/30/2022 Mylan Specialty L.P. Yupelri (Drug) Food and Beverage In-kind items and services $11.83 General
Category: Anticholinergics, Inhaled
02/09/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.72 General
Category: Cardiovascular & Metabolism
12/09/2021 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $102.55 General
Category: Pulmonology
06/16/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.15 General
Category: Cardiovascular & Metabolism
04/20/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.19 General
Category: Cardiovascular & Metabolism
01/25/2018 Medtronic USA, Inc. CAPSTONE (Device) Education In-kind items and services $144.89 General
Category: TL
10/05/2017 Respiratory Technologies, Inc. Food and Beverage Cash or cash equivalent $24.78 General
Category: Airway Clearance Therapy
01/06/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $10.50 General
Category: Cardiovascular & Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 429 666 $312,854 $75,869
2022 9 354 531 $272,964 $67,798
2021 12 434 684 $330,852 $85,758
2020 12 525 768 $396,369 $108,145
Total Patients
1,742
Total Services
2,649
Medicare Billing
$337,570
Procedure Codes
41

All Medicare Procedures & Services

41 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99291 Critical care, first 30-74 minutes Facility 2023 100 243 $170,586 $41,342 24.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 89 91 $58,058 $12,596 21.7%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 80 106 $37,100 $10,131 27.3%
99292 Critical care, each additional 30 minutes Facility 2023 41 88 $30,976 $7,534 24.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 41 57 $13,110 $3,622 27.6%
94727 Test to determine lung volumes using gas dilution or washout Facility 2023 26 27 $1,080 $248.04 23.0%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 26 27 $1,134 $212.16 18.7%
94729 Test to examine how well the lungs exchange gases Facility 2023 26 27 $810.00 $184.08 22.7%
99291 Critical care, first 30-74 minutes Facility 2022 87 238 $167,076 $41,986 25.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 79 81 $51,678 $12,675 24.5%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 75 82 $28,700 $6,741 23.5%
99292 Critical care, each additional 30 minutes Facility 2022 23 34 $11,968 $3,024 25.3%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2022 13 16 $7,280 $1,849 25.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 14 17 $3,910 $986.73 25.2%
94727 Test to determine lung volumes using gas dilution or washout Facility 2022 21 21 $840.00 $206.57 24.6%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2022 21 21 $882.00 $176.95 20.1%
94729 Test to examine how well the lungs exchange gases Facility 2022 21 21 $630.00 $153.10 24.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 92 281 $197,262 $50,070 25.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 74 78 $49,764 $12,438 25.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 83 106 $37,100 $8,995 24.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 57 81 $18,630 $4,782 25.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 28 34 $5,372 $2,321 43.2%
95810 Sleep monitoring of patient (6 years or older) in sleep lab Facility 2021 20 20 $5,040 $1,895 37.6%
99292 Critical care delivery critically ill or injured patient Facility 2021 18 21 $7,392 $1,814 24.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 14 14 $4,830 $1,597 33.1%

About Dr. Khalid Alhourani, MD

Dr. Khalid Alhourani, MD is a Critical Care Medicine healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1831232636.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khalid Alhourani, MD has received a total of $1,661 in payments from pharmaceutical and medical device companies, with $875.12 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($769.09).

As a Medicare-enrolled provider, Alhourani has provided services to 1,742 Medicare beneficiaries, totaling 2,649 services with total Medicare billing of $337,570. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Critical Care Medicine, Pulmonary Disease
  • Location Warwick, RI
  • Active Since 02/14/2007
  • Last Updated 09/19/2024
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1831232636

Products in Payments

  • SALVATION (Device) $769.09
  • AIR (Device) $157.93
  • CAPSTONE (Device) $144.89
  • Physio-Stim (Device) $131.77
  • Prolastin-C Liquid (Biological) $102.55
  • YUPELRI (Drug) $97.81
  • XARELTO (Drug) $70.56
  • OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $42.13
  • Yupelri (Drug) $33.74
  • BREZTRI (Drug) $26.31
  • CAMZYOS (Drug) $25.00
  • PREVNAR 20 (Biological) $20.04
  • ELIQUIS (Drug) $14.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Warwick